BriaCell Therapeutics Corp.
(NASDAQ:BCTX)
$4.93
-0.06 (-1.20%)
At Close: 4:00 PM
BCTX Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
BCTX Stock Price Today
BriaCell Therapeutics Corp. (BCTX) stock declined over -1.20% intraday to trade at $4.93 a share on NASDAQ. The stock opened with a loss of -11.42% at $4.42 and touched an intraday high of $4.42, falling -1.20% against the last close of $4.99. The BriaCell Therapeutics Corp. in stock market went to a low of $3.67 during the session.
BCTX Stock Snapshot
$4.99
Prev. Close
78.78 Million
Market Cap
$3.67
Day Low
$4.42
Open
N/A
Number of Shares
$4.42
Day High
N/A
P/E ratio
-1.30
EPS (TTM)
1.33
Cash Flow per Share
N/A
Free Float in %
-0.24
Book Value
130233.00
Volume
BCTX Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta1.31
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsJul. 2023
SectorHealthcare
IndustryBiotechnology
About Company
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Peers
Frequently Asked Questions
What is the current BriaCell Therapeutics Corp. (BCTX) stock price?
BriaCell Therapeutics Corp. (NASDAQ: BCTX) stock price is $4.93 in the last trading session. During the trading session, BCTX stock reached the peak price of $4.42 while $3.67 was the lowest point it dropped to. The percentage change in BCTX stock occurred in the recent session was -1.20% while the dollar amount for the price change in BCTX stock was -$0.06.
BCTX's industry and sector of operation?
The NASDAQ listed BCTX is part of Biotechnology industry that operates in the broader Healthcare sector. BriaCell Therapeutics Corp. , an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer.
Who are the executives of BCTX?
Dr. William V. Williams M.D.
Chief Executive Officer, Pres & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A., MBA
Chief Financial Officer & Corporation Sec.
Dr. William V. Williams M.D.
CEO, Pres & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.
CFO & Corp. Sec.
How BCTX did perform over past 52-week?
BCTX's closing price is 0.72% higher than its 52-week low of $3.67 where as its distance from 52-week high of $8.1 is -0.16%.
How many employees does BCTX have?
Number of BCTX employees currently stands at N/A. BCTX operates from Bellevue Centre, West Vancouver, BC V7T 2X1, CA.
Link for BCTX official website?
Official Website of BCTX is: https://www.briacell.com
How do I contact BCTX?
BCTX could be contacted at phone #604 921 1810 and can also be accessed through its website. BCTX operates from Bellevue Centre, West Vancouver, BC V7T 2X1, CA.
How many shares of BCTX are traded daily?
BCTX stock volume for the day was 130233.00 shares. The average number of BCTX shares traded daily for last 3 months was 97.04 Thousands.
What is the market cap of BCTX currently?
The market value of BCTX currently stands at $78.78 Million with its latest stock price at $4.93 and N/A of its shares outstanding.